256 related articles for article (PubMed ID: 7665550)
1. Topoisomerase poisons: harnessing the dark side of enzyme mechanism.
Froelich-Ammon SJ; Osheroff N
J Biol Chem; 1995 Sep; 270(37):21429-32. PubMed ID: 7665550
[No Abstract] [Full Text] [Related]
2. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
[TBL] [Abstract][Full Text] [Related]
3. ICE bioassay. Isolating in vivo complexes of enzyme to DNA.
Subramanian D; Furbee CS; Muller MT
Methods Mol Biol; 2001; 95():137-47. PubMed ID: 11089227
[No Abstract] [Full Text] [Related]
4. Iridoids as DNA topoisomerase I poisons.
Gálvez M; Martín-Cordero C; Ayuso MJ
J Enzyme Inhib Med Chem; 2005 Aug; 20(4):389-92. PubMed ID: 16206835
[TBL] [Abstract][Full Text] [Related]
5. F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action.
Perrin D; van Hille B; Barret JM; Kruczynski A; Etiévant C; Imbert T; Hill BT
Biochem Pharmacol; 2000 Apr; 59(7):807-19. PubMed ID: 10718339
[TBL] [Abstract][Full Text] [Related]
6. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
Tse-Dinh YC
Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase enzymes as drug targets.
Guichard SM; Danks MK
Curr Opin Oncol; 1999 Nov; 11(6):482-9. PubMed ID: 10550012
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activities of topopyrones.
Zaleski PA; Maini R; Leiris SJ; Elban MA; Hecht SM
J Nat Prod; 2012 Apr; 75(4):577-85. PubMed ID: 22462811
[TBL] [Abstract][Full Text] [Related]
9. Yeast systems for demonstrating the targets of anti-topoisomerase II agents.
Nitiss JL; Nitiss KC
Methods Mol Biol; 2001; 95():315-27. PubMed ID: 11089243
[No Abstract] [Full Text] [Related]
10. Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.
Levac P; Moss T
Chromosoma; 1996 Oct; 105(4):250-60. PubMed ID: 8854885
[TBL] [Abstract][Full Text] [Related]
11. Isolation of covalent enzyme-DNA complexes.
Rowe TC; Grabowski D; Ganapathi R
Methods Mol Biol; 2001; 95():129-35. PubMed ID: 11089226
[No Abstract] [Full Text] [Related]
12. DNA topoisomerases: essential enzymes and lethal targets.
Chen AY; Liu LF
Annu Rev Pharmacol Toxicol; 1994; 34():191-218. PubMed ID: 8042851
[No Abstract] [Full Text] [Related]
13. Lignans from the bark of Machilus thunbergii and their DNA topoisomerases I and II inhibition and cytotoxicity.
Li G; Lee CS; Woo MH; Lee SH; Chang HW; Son JK
Biol Pharm Bull; 2004 Jul; 27(7):1147-50. PubMed ID: 15256759
[TBL] [Abstract][Full Text] [Related]
14. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
Wong ML; Hsu MT
J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
[TBL] [Abstract][Full Text] [Related]
15. DNA topoisomerases I and II inhibitory activity of constituents isolated from Juglans mandshurica.
Li G; Lee SY; Lee KS; Lee SW; Kim SH; Lee SH; Lee CS; Woo MH; Son JK
Arch Pharm Res; 2003 Jun; 26(6):466-70. PubMed ID: 12877556
[TBL] [Abstract][Full Text] [Related]
16. Effects of DNA topoisomerase inhibitors on nonhomologous and homologous recombination in mammalian cells.
Aratani Y; Andoh T; Koyama H
Mutat Res; 1996 Feb; 362(2):181-91. PubMed ID: 8596537
[TBL] [Abstract][Full Text] [Related]
17. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
[TBL] [Abstract][Full Text] [Related]
18. [Poisons of DNA topoisomerases I and II].
Charcosset JY; Soues S; Laval F
Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of topoisomerases by fatty acids.
Suzuki K; Shono F; Kai H; Uno T; Uyeda M
J Enzyme Inhib; 2000; 15(4):357-66. PubMed ID: 10995067
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds.
Janočková J; Plšíková J; Kašpárková J; Brabec V; Jendželovský R; Mikeš J; Kovaľ J; Hamuľaková S; Fedoročko P; Kuča K; Kožurková M
Eur J Pharm Sci; 2015 Aug; 76():192-202. PubMed ID: 25960253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
